Product Code: GVR-4-68039-943-9
Nasal Packing Devices Market Growth & Trends:
The global nasal packing devices market size is anticipated to reach USD 276.8 million by 2030, growing at a CAGR of 5.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. This is attributed to the increasing prevalence of epistaxis and the ever-growing geriatric population. The demand for nasal packing devices is constantly on the rise, as epistaxis, also known as a nosebleed, is a commonly occurring condition. However, it is not severe in every case, and therefore people used to pay minute attention to it. But since the population has become increasingly health-conscious, many people opt to get it treated before the condition worsens.
The use of nasal packing devices increased significantly during the COVID-19 pandemic. The spread of the virus was a constant threat to healthcare professionals and patients during the pandemic. Hence, patients that suffered from epistaxis could be discharged from hospitals by applying nasal packing which, with little training, could be replaced and removed at home itself. This relieved the pressure on the hospital and minimized Epistaxis patient visits. Epistaxis, if left untreated, is a constantly occurring condition and can cause high discomfort and pain to the patient. In severe cases, it may also lead to fatality. Therefore, medical professionals first try to eliminate epistaxis through electric cauterization.
In case of failure of cauterization, nasal packing is used on the site of bleeding in the nasal cavity to create pressure and control the bleeding. In epistaxis conditions, a nasal packing can prove beneficial by achieving hemostasis, preventing desiccation, protecting the site from trauma, applying constant pressure to the mucosal walls, and protecting the nasal cavity. Nasal packing is highly used to control nasal bleeding as its advantages far outweigh the disadvantages. Post-packing care is taken by doctors to ensure patient safety. Manufacturers are also constantly investing in research and development of new products that can overcome these complications. In December 2020, Medtronic launched Novapak Nasal Sinus Packing and Stent, a single-use, dissolvable packing, intended post sinus surgery. It proved highly effective in bleeding control, prevention of adhesions, and providing a moist healing atmosphere for quick patient recovery.
Nasal Packing Devices Market Report Highlights:
- Based on type, the spray segment held a majority of the market share in terms of revenue in 2024 as they are extremely convenient to apply and eliminate the pain which is usually caused upon insertion and removal of traditional packing
- On the other hand, the gel segment is likely to witness the fastest growth rate during the forecast period due to its features such as high hemostatic properties
- Based on material, the non-absorbable segment dominated the market in terms of revenue share in 2024 pertaining to its cheaper price, better benefits, and increasing consumer preference
- The bio-resorbable segment is likely to grow at the fastest rate in the coming years due to the new technological developments and the introduction of new and advanced products into the market
- In 2024, North America dominated the market in terms of revenue share due to the growing adoption of nasal packing devices in the healthcare sector and the increasing number of epistaxis patients. In addition, a rise in COVID-19 cases in the region contributed to the market growth
- Asia Pacific is anticipated to witness a significant growth rate over the forecast period owing to the increase in the number of nasal packing manufacturers, high unmet needs, and improving healthcare infrastructure
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Type
- 1.2.3. Regional scope
- 1.2.4. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.4.5.1. Data for primary interviews in North America
- 1.4.5.2. Data for primary interviews in Europe
- 1.4.5.3. Data for primary interviews in Asia Pacific
- 1.4.5.4. Data for primary interviews in Latin America
- 1.4.5.5. Data for Primary interviews in MEA
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. Type outlook
- 2.3. Regional outlook
- 2.4. Competitive Insights
Chapter 3. Nasal Packing Devices Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Rising Incidence of nasal disorders
- 3.2.1.2. Minimally invasive treatment demand
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. High cost of advanced devices:
- 3.3. Nasal Packing Devices Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Bargaining power of suppliers
- 3.3.1.2. Bargaining power of buyers
- 3.3.1.3. Threat of substitutes
- 3.3.1.4. Threat of new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Economic landscape
- 3.3.2.3. Social landscape
- 3.3.2.4. Technological landscape
- 3.3.2.5. Environmental landscape
- 3.3.2.6. Legal landscape
Chapter 4. Nasal Packing Devices Market: Product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Nasal Packing Devices Market: Product Movement Analysis
- 4.3. Nasal Packing Devices Market by Product Outlook (USD Million)
- 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 4.5. Spray
- 4.5.1. Spray Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.6. Gel
- 4.6.1. Gel Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.7. Dressings
- 4.7.1. Dressings Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.8. Injectable
- 4.8.1. Injectable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Nasal Packing Devices Market: Type Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Nasal Packing Devices Market: Type Movement Analysis
- 5.3. Nasal Packing Devices Market by Type Outlook (USD Million)
- 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 5.5. Non-absorbable
- 5.5.1. Non-absorbable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6. Bioresorbable
- 5.6.1. Bioresorbable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Nasal Packing Devices Market: Regional Estimates & Trend Analysis
- 6.1. Regional Dashboard
- 6.2. Regional Nasal Packing Devices Market movement analysis
- 6.3. Nasal Packing Devices Market: Regional Estimates & Trend Analysis by Technology & Type
- 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 6.5. North America
- 6.5.1. North America Nasal Packing Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5.2. U.S.
- 6.5.2.1. Key Country Dynamics
- 6.5.2.2. Competitive Scenario
- 6.5.2.3. Regulatory Framework
- 6.5.2.4. Reimbursement scenario
- 6.5.2.5. U.S. Nasal Packing Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5.3. Canada
- 6.5.3.1. Key Country Dynamics
- 6.5.3.2. Competitive Scenario
- 6.5.3.3. Regulatory Framework
- 6.5.3.4. Reimbursement scenario
- 6.5.3.5. Canada Nasal Packing Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5.4. Mexico
- 6.5.4.1. Key Country Dynamics
- 6.5.4.2. Competitive Scenario
- 6.5.4.3. Regulatory Framework
- 6.5.4.4. Reimbursement scenario
- 6.5.4.5. Mexico Nasal Packing Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5.5. Europe
- 6.5.6. Europe Nasal Packing Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5.7. UK
- 6.5.7.1. Key Country Dynamics
- 6.5.7.2. Competitive Scenario
- 6.5.7.3. Regulatory Framework
- 6.5.7.4. Reimbursement scenario
- 6.5.7.5. UK Nasal Packing Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5.8. Germany
- 6.5.8.1. Key Country Dynamics
- 6.5.8.2. Competitive Scenario
- 6.5.8.3. Regulatory Framework
- 6.5.8.4. Reimbursement scenario
- 6.5.8.5. Germany Nasal Packing Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5.9. France
- 6.5.9.1. Key Country Dynamics
- 6.5.9.2. Competitive Scenario
- 6.5.9.3. Regulatory Framework
- 6.5.9.4. Reimbursement scenario
- 6.5.9.5. France Nasal Packing Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5.10. Italy
- 6.5.10.1. Key Country Dynamics
- 6.5.10.2. Competitive Scenario
- 6.5.10.3. Regulatory Framework
- 6.5.10.4. Reimbursement scenario
- 6.5.10.5. Italy Nasal Packing Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5.11. Spain
- 6.5.11.1. Key Country Dynamics
- 6.5.11.2. Competitive Scenario
- 6.5.11.3. Regulatory Framework
- 6.5.11.4. Reimbursement scenario
- 6.5.11.5. Spain Nasal Packing Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5.12. Denmark
- 6.5.12.1. Key Country Dynamics
- 6.5.12.2. Competitive Scenario
- 6.5.12.3. Regulatory Framework
- 6.5.12.4. Reimbursement scenario
- 6.5.12.5. Denmark Nasal Packing Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5.13. Sweden
- 6.5.13.1. Key Country Dynamics
- 6.5.13.2. Competitive Scenario
- 6.5.13.3. Regulatory Framework
- 6.5.13.4. Reimbursement scenario
- 6.5.13.5. Sweden Nasal Packing Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5.14. Norway
- 6.5.14.1. Key Country Dynamics
- 6.5.14.2. Competitive Scenario
- 6.5.14.3. Regulatory Framework
- 6.5.14.4. Reimbursement scenario
- 6.5.14.5. Norway Nasal Packing Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6. Asia Pacific
- 6.6.1. Asia Pacific Nasal Packing Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.2. Japan
- 6.6.2.1. Key Country Dynamics
- 6.6.2.2. Competitive Scenario
- 6.6.2.3. Regulatory Framework
- 6.6.2.4. Reimbursement scenario
- 6.6.2.5. Japan Nasal Packing Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.3. China
- 6.6.3.1. Key Country Dynamics
- 6.6.3.2. Competitive Scenario
- 6.6.3.3. Regulatory Framework
- 6.6.3.4. Reimbursement scenario
- 6.6.3.5. China Nasal Packing Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.4. India
- 6.6.4.1. Key Country Dynamics
- 6.6.4.2. Competitive Scenario
- 6.6.4.3. Regulatory Framework
- 6.6.4.4. Reimbursement scenario
- 6.6.4.5. India Nasal Packing Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.5. South Korea
- 6.6.5.1. Key Country Dynamics
- 6.6.5.2. Competitive Scenario
- 6.6.5.3. Regulatory Framework
- 6.6.5.4. Reimbursement scenario
- 6.6.5.5. South Korea Nasal Packing Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.6. Australia
- 6.6.6.1. Key Country Dynamics
- 6.6.6.2. Competitive Scenario
- 6.6.6.3. Regulatory Framework
- 6.6.6.4. Reimbursement scenario
- 6.6.6.5. Australia Nasal Packing Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.7. Thailand
- 6.6.7.1. Key Country Dynamics
- 6.6.7.2. Competitive Scenario
- 6.6.7.3. Regulatory Framework
- 6.6.7.4. Reimbursement scenario
- 6.6.7.5. Thailand Nasal Packing Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.7. Latin America
- 6.7.1. Latin America Nasal Packing Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.7.2. Brazil
- 6.7.2.1. Key Country Dynamics
- 6.7.2.2. Competitive Scenario
- 6.7.2.3. Regulatory Framework
- 6.7.2.4. Reimbursement scenario
- 6.7.2.5. Brazil Nasal Packing Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.7.3. Argentina
- 6.7.3.1. Key Country Dynamics
- 6.7.3.2. Competitive Scenario
- 6.7.3.3. Regulatory Framework
- 6.7.3.4. Reimbursement scenario
- 6.7.3.5. Argentina Nasal Packing Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.8. Middle East & Africa
- 6.8.1. Middle East & Africa Nasal Packing Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.8.2. South Africa
- 6.8.2.1. Key Country Dynamics
- 6.8.2.2. Competitive Scenario
- 6.8.2.3. Regulatory Framework
- 6.8.2.4. Reimbursement scenario
- 6.8.2.5. South Africa Nasal Packing Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.8.3. Saudi Arabia
- 6.8.3.1. Key Country Dynamics
- 6.8.3.2. Competitive Scenario
- 6.8.3.3. Regulatory Framework
- 6.8.3.4. Reimbursement scenario
- 6.8.3.5. Saudi Arabia Nasal Packing Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.8.4. UAE
- 6.8.4.1. Key Country Dynamics
- 6.8.4.2. Competitive Scenario
- 6.8.4.3. Regulatory Framework
- 6.8.4.4. Reimbursement scenario
- 6.8.4.5. UAE Nasal Packing Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.8.5. Kuwait
- 6.8.5.1. Key Country Dynamics
- 6.8.5.2. Competitive Scenario
- 6.8.5.3. Regulatory Framework
- 6.8.5.4. Reimbursement scenario
- 6.8.5.5. Kuwait Nasal Packing Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
- 7.1. Market Participant Categorization
- 7.2. Key Company Profiles
- 7.2.1. Summit Health
- 7.2.1.1. Company overview
- 7.2.1.2. Financial performance
- 7.2.1.3. Product benchmarking
- 7.2.1.4. Strategic initiatives
- 7.2.2. Smith & Nephew
- 7.2.2.1. Company overview
- 7.2.2.2. Financial performance
- 7.2.2.3. Product benchmarking
- 7.2.2.4. Strategic initiatives
- 7.2.3. Stryker Corporation
- 7.2.3.1. Company overview
- 7.2.3.2. Financial performance
- 7.2.3.3. Product benchmarking
- 7.2.3.4. Strategic initiatives
- 7.2.4. Medtronic plc.
- 7.2.4.1. Company overview
- 7.2.4.2. Financial performance
- 7.2.4.3. Product benchmarking
- 7.2.4.4. Strategic initiatives
- 7.2.5. Network medical products ltd.
- 7.2.5.1. Company overview
- 7.2.5.2. Financial performance
- 7.2.5.3. Product benchmarking
- 7.2.5.4. Strategic initiatives
- 7.2.6. Olympus
- 7.2.6.1. Company overview
- 7.2.6.2. Financial performance
- 7.2.6.3. Product benchmarking
- 7.2.6.4. Strategic initiatives
- 7.2.7. Lohmann & Rauscher
- 7.2.7.1. Company overview
- 7.2.7.2. Financial performance
- 7.2.7.3. Product benchmarking
- 7.2.7.4. Strategic initiatives
- 7.2.8. Meril Life Sciences Pvt Ltd.
- 7.2.8.1. Company overview
- 7.2.8.2. Financial performance
- 7.2.8.3. Product benchmarking
- 7.2.8.4. Strategic initiatives
- 7.2.9. FABCO
- 7.2.9.1. Company overview
- 7.2.9.2. Financial performance
- 7.2.9.3. Product benchmarking
- 7.2.9.4. Strategic initiatives
- 7.2.10. Aegis Lifesciences
- 7.2.10.1. Company overview
- 7.2.10.2. Financial performance
- 7.2.10.3. Product benchmarking
- 7.2.10.4. Strategic initiatives